Videos

From interpreting currently-understood risks to managing isolation-induced indoor allergen exposure, asthmatics may have concerns they address with clinicians.

Surveyed patients discharged from the hospital are reporting respiratory burdens beyond 6 months. Are outpatient facilities equipped to manage COVID-19 long haulers?

How dupilumab is observed to benefit EoE patients—and who may administer the biologic therapy.

An interview on the TSLP inhibitor's effect on exacerbations, hospitalizations, and disease progress over 52-week findings.

Perspective on how the interleukin-targeting biologic has unique benefit for the rare, under-resourced disease.

Lisa Sarfaty, director of strategic planning for the National Organization for Rare Disorders, speaks on the role of the organization and the importance of the Rare Disease Day campaign.

New survey results depict unexpected burdens in long-haul patients, as well as continued issues following rehabilitation.

An interview with a study author on new interpretations of biologic asthma benefit.

A discussion on continued research into the first regulated treatment for pediatric peanut allergy.

Unhealthy lifestyles during the pandemic may increase the risk of cardiovascular disease.

Due to taboo or stigma, patients may not openly discuss their leg ulcers with their providers.

An expert discusses findings that showed voxelotor (Oxbryta) improved leg ulcers in patients with sickle cell disease.

Dr. Khan discusses some of the risk factors associated with CHD.

A Stanford Cardiovascular Institute expert details a recent review into managing a growing field of agents.

Two pediatric cardiologists stress that recognizing symptoms of MIS-C is essential for primary care providers.

Two pediatric cardiologists offer perspective on how to approach conversations about MIS-C with parents or guardians.